Trial
NCT02226341
ACTHar in the Treatment of Lupus Nephritis
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Lupus Nephritis
Intervention
CellCept
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-07